CELLS IA TECHNOLOGIES, S.L.

Cells IA Technologies S.L. is a Madrid-based technology company specializing in digital and computational pathology. Its NucleIQ® platform integrates pathology workflows, Whole Slide Image (WSI) visualization, and AI-generated predictions to support diagnostic decision-making. The company develops AI solutions for several clinical areas, including breast, gastrointestinal, skin, urology, lung, and mitosis analysis, aiming to improve diagnostic accuracy, efficiency, and standardization. Its capabilities include histological image analysis, biomarker quantification such as PD-L1, and mitosis detection in tumor tissue. Cells IA focuses on modernizing pathology services through intuitive tools, LIS integration, and the ability to manage and analyze large volumes of medical imaging data.